Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
34,505,931
-
Shares change
-
+644,894
-
Total reported value, excl. options
-
$852,616,782
-
Value change
-
+$16,849,564
-
Number of buys
-
37
-
Number of sells
-
-45
-
Price
-
$24.71
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q2 2021
109 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q2 2021.
Avidity Biosciences, Inc. - Common Stock (RNA) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,505,931 shares
of 149,544,182 outstanding shares and own 23.07% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3,995,000 shares), FMR LLC (3,394,315 shares), BlackRock Inc. (2,700,365 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,537,071 shares), Cormorant Asset Management, LP (2,228,667 shares), EcoR1 Capital, LLC (2,103,950 shares), FEDERATED HERMES, INC. (1,970,916 shares), STATE STREET CORP (1,343,118 shares), VANGUARD GROUP INC (1,271,798 shares), and Matrix Capital Management Company, LP (1,200,000 shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.